IDSA Letter to WHO on Prioritizing Antimicrobial Resistant Pathogens (PDF)
IDSA reached out to World Health Organization Director Dr. Margaret Chan on the need to prioritize antimicrobial resistant pathogens as it develops its Global R&D Priority Pathogens List.
IDSA Statement to Senate HELP Committee on Laboratory Developed Tests (PDF)
IDSA provided a statement at the Senate Health, Education, Labor and Pensions (HELP) Committee hearing on laboratory developed tests (LDTs) regarding the important role they play in infectious disease clinical care, public health, and on the potential impact proposed new regulations may have on innovation and patient access to testing.
IDSA Letter Urges Congress to Provide 2017 Funding for ID Programs (PDF)
In a letter to leaders of the House and Senate spending committees, IDSA urged support for federal infectious diseases programs. The letter also asked appropriators to complete the funding process before the end of the year.
IDSA Leads Organizations in Advocacy for Implementation of NIH Physician Scientist Workforce Recommendations (PDF)
IDSA was joined by 35 other health groups in a letter to NIH Director Francis Collins requesting an update on efforts to bolster the physician-scientist workforce.
IDSA Engages House Subcommittee Ahead of Hearing on Antibiotic Resistance (PDF)
In advance of a hearing on federal efforts to address antibiotic resistance, IDSA wrote to leaders of the Subcommittee to urge support for implementation of the National Action Plan for Combating Antibiotic-Resistance Bacteria. The letter placed particular emphasis on antibiotic stewardship, incentives to spur R&D, ID workforce challenges, and the need for increased funding for federal AR programs.
IDSA Zika Vote Statement (PDF)
IDSA urges Congress to pass the strongest emergency bill possible to combat Zika and to reject efforts to fund the Zika response at the expense of equally critical health funding.
IDSA, ASM, and PASCV Letter to FDA on LDTs (PDF)
IDSA, ASM and the Pan-American Society for Clinical Virology urge FDA to consider the vital role of lab developed tests in rapidly diagnosing and appropriately treating infectious diseases.
PACCARB Press Release
Recommendations from the Presidential Advisory Council on Combating Antibiotic Resistant Bacteria reflect IDSA input.
1 of 8
CDC Updates Guidance for Pregnant Women and Women and Men of Reproductive Age for Zika Virus Infection
The U.S. Centers for Disease Control and Prevention (CDC) previously issued travel, testing, and other guidance related to areas of active Zika virus transmission in Florida.
CDC Advises Hospitals to Alert Patients at Risk from Contaminated Heater-Cooler Devices Used during Cardiac Surgery
The Centers for Disease Control and Prevention (CDC) is advising hospitals to notify patients who underwent open-heart (open-chest) surgery involving a Stöckert 3T heater-cooler that the device was potentially contaminated, possibly putting patients at risk for a life threatening infection.
Zika Virus Infection Related to the Ongoing Investigation of Local Mosquito-borne Zika Virus Transmission in Miami-Dade County, Florida
FDA issues final rule on safety and effectiveness of antibacterial soaps
FDA Advises Testing for Zika Virus in All Donated Blood in the US
August Update: Interim Guidance: Infants with Possible Congenital Zika Virus Infection
July 2016 Safety Labeling Changes posting includes 52 products
FDA approves first generic version of widely used influenza drug
Read More >>
This World AIDS Day finds us at a pivotal moment, appreciating the progress that has led to 18 million people worldwide receiving treatment that prevents illness and transmission of HIV and accepting the challenge of extending that essential intervention to the 15 million living with HIV still in need of medicine.
ARLINGTON, Va. - Pledging to continue the Infectious Diseases Society of America's (IDSA) commitment to improving the health of all people, communities and society, William G. Powderly, MD, FIDSA, assumes the reins as the new president of IDSA. He will be joined by dedicated, experienced Board members as well as new additions who bring expertise in areas ranging from diagnostics and HIV to compensation, pediatrics and guidelines development.
ARLINGTON, Va. - Driven by burgeoning ecotourism and military campaigns in Iraq and Afghanistan, a parasitic infection called leishmaniasis is showing up in more U.S. patients, often stumping doctors. Rapid diagnostic tests and innovative treatments are among the strategies to address leishmaniasis highlighted in new guidelines released by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH) and published in the journal Clinical Infectious Diseases.
>> Read More
Among people living with HIV in the U.S. who smoke, smoking may shorten lifespan more than HIV itself, a new JID study suggests.
Press Release 10 28 2016 2
NEW ORLEANS - A complication of measles that kills children years after they have the infection is more common than thought, according to a study being presented at IDWeek 2016™. The research underscores the vital importance of herd immunity by vaccination: All who are eligible should be vaccinated to protect those who can't be immunized, including infants.
NEW ORLEANS – A new biologic medication – the first for HIV – is showing promise in treating patients with multidrug resistance, according to phase 3 research being presented at IDWeek 2016™.
NEW ORLEANS – That twice-yearly trip to the dentist could do more than keep teeth and gums healthy: It may decrease the risk of pneumonia by
reducing bacteria in the mouth, suggests research being presented at IDWeek 2016™.
1 of 7
1300 Wilson Boulevard Suite 300 Arlington, VA 22209 | Phone: (703) 299-0200 | Fax: (703) 299-0204
| HIVMA | Contact Us
© Copyright IDSA 2016 Infectious Diseases Society of America